Physician
Churrango, Jose
Churrango, Jose was paid $67K by Medicaid between Feb 2018 and May 2022, across 6 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 73% of everything it billed.
33Billing provider infoCHURRANGO, JOSE
NEWBURGH, NY 12550
NEWBURGH, NY 12550
33aNPI1386879914assigned 05/27/2009
33bProvider typeGastroenterology Physician
28Total paid$67K
24GClaims827
24DCodes billed6
24AFirst – last monthFeb 2018 – May 2022
Compared with peers
Next to other Gastroenterology Physician providers in New York
Rank by total paid#198 of 656
Median peer was paid$12K
This provider vs. median5.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39 | $3K | |
| 2019 | 193 | $14K | |
| 2020 | 171 | $12K | |
| 2021 | 348 | $31K | |
| 2022 | 76 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 73% | 567 | 550 | $49K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 174 | 174 | $9K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.4% | 37 | 37 | $6K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.1% | 12 | 12 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 12 | 12 | $935.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 25 | 24 | $505.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.